Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-10-11

FDA Approved: HYCAMTIN — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved HYCAMTIN (topotecan) from Sandoz as the original application; the initial indications included treatment of relapsed small cell lung cancer and rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hycamtin (Topotecan)

Snippet

ORIG AP for HYCAMTIN (TOPOTECAN)